Cann Group Ltd
CAN
Company Profile
Business description
Cann Group Ltd is an Australia-based company engaged in the cultivation, manufacture, and supply of medicinal cannabis products for medicinal and research purposes. The company offers dried cannabis flower, oils, and other medicinal cannabis products. It also develops and manufactures finished product formulations through third-party arrangements. Geographically, the company generates revenue from Australia, the United Kingdom, and New Zealand, with the majority of its revenue generated from Australia.
Contact
23 Greentek Court
KoorlongVIC3501
AUST: +61 390957088
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
40
Stocks News & Analysis
stocks
Meta earnings: Early look at Muse adoption impresses investors
We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.
stocks
Tesla earnings: Shares fall on slower deliveries growth outlook; Raising valuation
Our increased valuation comes from higher full self-driving adoption assumptions and a lower near- and medium-term capital expenditures forecast.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,889.20 | 27.90 | -0.31% |
| CAC 40 | 7,811.26 | 110.42 | -1.39% |
| DAX 40 | 25,371.75 | 273.29 | -1.07% |
| Dow JONES (US) | 52,867.98 | 11.89 | 0.02% |
| FTSE 100 | 10,725.03 | 27.85 | -0.26% |
| HKSE | 23,066.79 | 132.11 | 0.58% |
| NASDAQ | 26,008.86 | 694.00 | -2.60% |
| Nikkei 225 | 62,336.60 | 571.24 | -0.91% |
| NZX 50 Index | 13,706.42 | 40.42 | -0.29% |
| S&P 500 | 7,663.43 | 93.74 | -1.21% |
| S&P/ASX 200 | 8,780.20 | 13.00 | -0.15% |
| SSE Composite Index | 3,614.12 | 43.90 | -1.20% |